In her letter to the Medical Superintendent, Head of the Department of Anaesthesiology, Dr Chandralekha asked the hospital head to review stock of life saving drugs which are used in emergency situations quite often.
As per the letter, Dr Chandralekha's husband recently developed severe urticaria all over the body after consuming the some drugs from the hospital's store.
As his condition worsened he was prescribed heavy doses of anti-allergic drugs. The treatment went on for five days.
In view of this, the treatment was reviewed and it was decided to stop one of the tablets and change the brand and the new drug was purchased from the market," she said.
After that the condition of the patient started showing improvement.
"The problem could be detected just because we are living in the campus, having pool of doctors around us watching patient personally," Chandralekha said.
She said,"Samples are being sent to you duly signed by me, for review, and such spurious life saving drugs should be withdrawn and banned immediately."
According to the hospital sources, the samples have been sent for testing and one company has already been debarred.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
